Skip to main content
Clinical Trials/NCT05711147
NCT05711147
Active, not recruiting
Phase 3

One-time Abutment Placement Versus 4 Times Abutment Removal on Interproximal Bone Levels and Peri-implant Soft Tissues: a Prospective Randomized Clinical Trial

Universidad Complutense de Madrid1 site in 1 country43 target enrollmentDecember 1, 2017

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Dental Implant
Sponsor
Universidad Complutense de Madrid
Enrollment
43
Locations
1
Primary Endpoint
Changes in interproximal bone levels
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

Introduction: the repeated connection and disconnection of healing abutments during dental implants´ osseointegration has been associated with significant increased peri-implant bone loss, when compared with placing the final prosthetic abutment during implant placement surgery and non-removing it ever again. Previous data from animal studies suggests that the higher the number of removals of the healing abutments, the greater the bone resorption around implants, however the evidence in humans is scarce and heterogeneous. Furthermore, this greater bone resorption has been claimed to be associated to the inflammatory status of the peri-implant soft tissues, which would be greater as a consequence of the repeated disruption of the soft-tissues attachment to the prosthetic abutment, and the hypothetical microbial contamination of the implant-abutment interphase, induced by the repeated manipulation of the prosthetic components.

Objective: to evaluate the changes in peri-implant crestal bone levels between two prosthetic protocols, the control being the conventional protocol where healing abutments are placed during surgery and removed four times before the delivery of the final abutment and prostheses, and the test protocol where definitive abutments are placed immediately after implant placement and are not removed ever again.

Material and methods: 80 platform switched implants will be placed in the posterior maxilla or mandible of 40 partial edentulous patients. Immediately after implant placement, patients will be randomized to receive the definitive abutment at the moment of implant placement (one abutment-one time protocol), or 12 weeks later, after removing the healing abutment four times during the confection of the final prostheses, following the conventional protocol for implant supported restorations. The day of prostheses delivery, a mucosal biopsy from the implant surrounding tissues will be taken for histomorphometric and immunohistochemical analyses of the inflammatory response of the peri-implant soft tissues. Radiographic assessment of vertical bone level changes (primary outcome), clinical status of peri-implant tissues, changes in soft tissues margin, patient related outcomes and adverse events will be assessed at 6, 12, 24 and 36 months after loading.

Registry
clinicaltrials.gov
Start Date
December 1, 2017
End Date
December 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ana Molina Villar

Assistant Professor

Universidad Complutense de Madrid

Eligibility Criteria

Inclusion Criteria

  • At least two adjacent missing teeth in the posterior maxilla or mandible (positions 4 to 7)
  • Willing to receive implant supported fixed partial dentures
  • There must be a natural tooth mesial to the most proximal implant site, however free end situations will be allowed for the distal implants
  • Healed sites (minimum 12 weeks post-extraction)
  • In the case of prior bone augmentation, a minimum of 6 months of healing is required
  • Simultaneous bone augmentation will be allowed only for close sinus lifting

Exclusion Criteria

  • Systemic exclusion criteria:
  • Medical conditions requiring prolonged use of steroids and/or medications that can interfere with bone metabolism
  • History of leukocyte dysfunction and deficiencies
  • History of neoplastic disease requiring the use of radiation or chemotherapy
  • History of renal failure
  • Metabolic disorders such as osteoporosis
  • History of uncontrolled endocrine disorders
  • Physical handicaps that would interfere with the ability to perform adequate oral hygiene
  • Alcoholism or drug abuse
  • History of immunodeficiency syndromes

Outcomes

Primary Outcomes

Changes in interproximal bone levels

Time Frame: Implantation, prosthesis loading, 6 months, 12 months, 24 months, 36 months

Changes at the mesial and distal crestal bone levels measured in periapical digital radiographs at the mesial and distal implant aspects

Secondary Outcomes

  • Mobility(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Clinical crown length of the implant supported crown(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Papilla index(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Immunohistochemical analysis of the histologic sections(Prosthesis loading)
  • Keratinized peri-implant mucosa(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Modified plaque index(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Probing depth(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Clinical crown length of the adjacent tooth(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Sulcus bleeding index(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Adverse events(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Patient-reported outcomes(Prosthesis loading, 6 months, 12 months, 24 months, 36 months)
  • Hystomorphometric analysis of soft tissue biopsy samples(Prosthesis loading)

Study Sites (1)

Loading locations...

Similar Trials